PC(22:2(13Z,16Z)/20:2(11Z,14Z))

Term ID

CHEBI:88871

Synonyms

(2-{[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
1-Docosadienoyl-2-eicosadienoyl-sn-glycero-3-phosphocholine
GPCho(22:2/20:2)
GPCho(22:2n6/20:2n6)
GPCho(22:2w6/20:2w6)
GPCho(42:4)
Lecithin
PC aa C42:4
PC(22:2/20:2)
PC(22:2n6/20:2n6)
PC(22:2w6/20:2w6)
PC(42:4)
Phosphatidylcholine(22:2/20:2)
Phosphatidylcholine(22:2n6/20:2n6)
Phosphatidylcholine(22:2w6/20:2w6)
Phosphatidylcholine(42:4)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PC(22:2(13Z,16Z)/20:2(11Z,14Z))

Phenotype where environments contain PC(22:2(13Z,16Z)/20:2(11Z,14Z))

Phenotype modified by environments containing PC(22:2(13Z,16Z)/20:2(11Z,14Z))

Phenotype affecting PC(22:2(13Z,16Z)/20:2(11Z,14Z))

Human Disease Model